Soulzac 20 mg/5 ml Oral Solution

Soulzac 20 mg/5 ml Oral Çözelti

Treatment areas:

Adults SOULZAC is indicated for the treatment of depression, obsessive-compulsive disorder and bulimia nervosa. Children and adolescents aged 8 years and older: It is indicated for the treatment of moderate to severe major depressive disorder that has not responded to 4-6 sessions of psychoterapy. Only in combination with psychotherapy is recommended for a child or adolescent with moderate to severe major depressive disorder.

Treatment Classes:

N06AB03 - Selective serotonin reuptake inhibitors

Active substances:

Fluoksetin

Form:

Oral drops

Commercial form:

bottles of 70 ml

Prospectus:

BACK